Matches in DBpedia 2016-04 for { ?s ?p "Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack).The study was prematurely stopped and thus it could not be determined whether terutroban has a better effect than aspirin."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Terutroban abstract "Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack).The study was prematurely stopped and thus it could not be determined whether terutroban has a better effect than aspirin.".
- Q7705345 abstract "Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack).The study was prematurely stopped and thus it could not be determined whether terutroban has a better effect than aspirin.".
- Terutroban comment "Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack).The study was prematurely stopped and thus it could not be determined whether terutroban has a better effect than aspirin.".
- Q7705345 comment "Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack).The study was prematurely stopped and thus it could not be determined whether terutroban has a better effect than aspirin.".